Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Novartis first to benefit from NICE advice on ‘patient preference’

February 18, 2019

http://www.pmlive.com/pharma_news/novartis_first_to_benefit_from_nice_advice_on_patient_preference_1278304

Posted in: Uncategorized

Post navigation

← NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice
UHC Act: The role of Health Technology →

News

MINISTERIO DE SALUD Y DESARROLLO SOCIAL SECRETARÍA DE GOBIERNO DE SALUD
Technologies de santé : Dr Mouna Jameleddine nommée présidente de la Table ronde ISPOR pour le MOA
Dr. Brian O’Rourke to Retire as CADTH’s President and CEO
MOH inaugurates Steering and Technical committees for Health Technology Assessment
Sir Andrew Dillon to stand down as NICE chief executive
INAHTA welcomes NICE, UK as newest member
INAHTA welcomes SEC, Ukraine, as Candidate Member
HIQA signs memorandum of understanding to support health technology assessment in Ireland, Scotland and Wales
Growing Patient Involvement in Health Technology Assessment (HTA)
NICE launches online resource to help development and adoption of new health technologies

Twitter

Tweets about #HTA

#HTA

Retweet on TwitterAdvocacy Network Africa Retweeted
majdzadehrReza Majdzadeh@majdzadehr·
2 Dec

A MUST SEE VIDEO shows the definition, process, and commitment to the Universal Health Coverage-Priority Benefits Package. 🧐https://youtu.be/lmnynwLxCmE🧐
@UHCPartnership @asoucat @AwadMataria @decide_health @WHOEMRO @decide_health @DCPThree @KarinEEStenberg @DCPThree @UHC2030 #HTA

Reply on Twitter 1201563375983058945Retweet on Twitter 12015633759830589456Like on Twitter 12015633759830589458Twitter 1201563375983058945
ambrishagastyaAmbrish Singh@ambrishagastya·
8h

pCODR decisions and access to anticancer treatment in Canada.

#HTA #HEOR #healthtechnologyassessment #HTAi2018
Slides📰👇
https://youtu.be/zxixPa9eDuo

Reply on Twitter 1203117501757870080Retweet on Twitter 1203117501757870080Like on Twitter 1203117501757870080Twitter 1203117501757870080
Retweet on TwitterRebel nation Retweeted
bighig77Ryan Higdon@bighig77·
10h

My 2019 Fatboys!!!!! Not a lot of fat but a whole LOT of heart! #LeadFromTheFront #HTA

Reply on Twitter 1203080212428271616Retweet on Twitter 12030802124282716164Like on Twitter 120308021242827161624Twitter 1203080212428271616
Load More...
Privacy Policy | Disclaimer
Copyright © 2019 ISPOR – The Professional Society for Health Economics and Outcomes Research